Girihlet’s T and B cell sequencing assays and immune map database allow predictions and measurements on a person’s health status and provide an un understanding of the immune system in order to treat cancer, allergies, infections and autoimmune disease.
Timeline
August 2018
Girihlet raises a $2,500,000 seed round from Digitalis Ventures and True Ventures.
September 2015
Girihlet raises a $250,000 seed round from IndieBio and SOSV.
Funding rounds
Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
People
Name
Role
LinkedIn
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services